FDA Inspection
Saptalis Pharmaceuticals LLCSaptalis Pharmaceuticals LLC – FDA Inspection, Oct 30, 2018
Record Details
This FDA Inspection record concerns Saptalis Pharmaceuticals LLC, with an inspection on October 30, 2018, issued by the New York District Office, covering human drugs.
View Company Profile
ID · 75bea956-e0a3-4a07-96cc-78297b25b90b
Inspection Facts
- Inspection number
- 1072233
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Saptalis Pharmaceuticals LLC
4| Date | Classification | Office | Project area |
|---|---|---|---|
| March 6, 2026 | Not classified | New York District Office | Drug Quality Assurance |
| September 9, 2025 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| March 17, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 28, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Saptalis Pharmaceuticals LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.